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ABSTRACT
The pattern electroretinogram is an electrophysiological test that assesses the
function of inner retinal layers, particularly the ganglion cells layer of retina, using a
reversing checkerboard or grating pattern that produces no change in average
luminance over time. The normal pattern electroretinogram is composed of a proemi-
nent positive component (P50) and a large later negative component (N95). Since
structural damage that compromises the retinal ganglion cell layer can lead to pattern
electroretinogram changes, particularly in the N95 amplitude, the test can be useful
in the treatment of a number of anterior visual pathway diseases. In this article, we
review the methods for recording pattern electroretinogram and its usefulness in the
diagnosis and management of diseases including inflammatory, hereditary, ischemic
and compressive lesions of the anterior visual pathway.
Keywords: Electroretinography/methods; Optic nerve injuries; Retina/physiopatho-
logy; Optic nerve diseases/diagnosis; Pattern recognition, visual; Vision Disorders/diag-
nosis; Visual Pathways/pathology
RESUMO
O eletroretinograma de padrão reverso é um teste eletrofisiológico que avalia a função
das camadas internas da retina, especialmente a camada de células ganglionares,
através de um estímulo em xadrez ou em barras que não apresenta variação na lumi-
nância do estímulo. É composto de um componente positivo (P50) e um componente
negativo (N95) tardio. Uma vez que lesões estruturais às células ganglionares da reitna
podem levar a alterações no eletroretinograma de padrão reverso, especialmente na
amplitude da onda N95, o teste pode ser útil no tratamento de várias doenças da via
óptica anterior. Neste artigo revisamos os métodos de obtenção do eletroretinograma de
padrão reverso e a sua utilidade no diagnóstico e acompanhamento de doenças incluin-
do lesões inflamatórias, hereditárias, isquemicas e compressivas na via óptica anterior.
Descritores: Eletrorretinografia/métodos; Traumatismos do nervo óptico; Retina/fisio-
patologia; Doenças do nervo óptico/diagnóstico; Reconhcimento visual de modelos;
Transtornos da visão/diagnóstico; Vias visuais/patologia
INTRODUCTION
Disorders of the anterior visual pathway are the most frequent
and important diseases in neuro-ophthalmology and include com-
pressive, inflammatory, ischemic, toxic, deficient, degenerate, and
traumatic lesions. In such conditions, measurement of the degree
of retinal and optic nerve structural impairment is of great impor-
tance in the diagnosis and management. The main structural change
related to these diseases occurs in the retinal nerve fiber layer
(RNFL), which is composed of axons of retinal ganglion cells (RGC).
Thus, various methods have been used to morphologically and func-
tionally evaluate this cell population. Optical coherence tomogra-
phy (OCT), for example, is capable of measuring peripapillary retinal
nerve fiber layer (RNFL) and macula thickness(1-3), thus making it pos-
sible to quantify axonal injury in the retina. Axonal loss may also be
measured by scanning laser polarimetry, although with a poorer per-
formance in relation to OCT(4).
Another way of evaluating the RGC function is through electro-
physiological tests, particularly the pattern-reversal electroretino-
gram (PERG). Although PERG was conceived in 1964, only recently
has it had a greater application in relation to the quantification of
neural loss for diseases of the optic nerve(5-7). However, the majority
of PERG studies were performed in glaucoma patients(8).
The purpose of this paper is to review the characteristics and
techniques for obtaining PERG and review the abnormalities obser-
ved with this technology in the most important neuro-ophthalmo-
logical disorders of the anterior visual pathway, including heredi-
tary, inflammatory, demyelinating, ischemic, and compressive lesions
of optic chiasm nerves.
TYPES OF RESPONSE AND METHODS
PERG is an electrophysiological test that objectively evaluates
the function of the central retina generated by a stimulus structure
in the form of a checkerboard or bars, generally in black and white,
that alternates with a regular frequency and a constant luminance(9).
The response obtained by PERG expresses the function of the most
internal retinal layers, particularly the RGC layer(10). According to the
reversal frequency, two types of PERG can be obtained: stationary or
transitory. When the stimulus presents less than <7 reversals/sec,
PERG is said to be transient and the final wave obtained is composed
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of three components: N35, a small negative component with a peak
time occurring around 35 ms; P50, a prominent positive wave
emerging around 50 ms and N95, a wide negative wave around 95 ms.
(Figure 1) When a high reversal index is used, PERG is considered to
be at a steady-state and the wave acquires a sinusoidal form(9).
When analyzing transient PERG results, the latencies and ampli-
tudes of the P50 and N95 peaks are taken into account. The P50
amplitude is measured from the minimum point of the N35 valley
to the P50 peak, and the N95 amplitude is measured from P50 peak
to the minimum point of the N95 valley (Figure 1). In some patients,
the N35 deflection is poorly defined. In these cases, the average
N35 is used, which is obtained between the baseline at time zero
and the beginning of the deflection of P50. The peak times (impli-
cit time) are measured from the beginning of the stimulus to the
maximum or minimum point of each wave, taking into account the
ideal form of the wave. The peak times are erroneously called
latencies because they refer to the time between the stimulus and
the beginning of the deflection of the wave, not the maximum
activity of the peak(11).
The response generated by the pattern-reversal stimulus has a
small amplitude and varies considerably depending on the techni-
que that is used. The International Society for Clinical Electrophy-
siology of Vision (ISCEV) has stablished parameters for examinations
with the goal of reducing differences among laboratories, impro-
ving the appearance of the wave, making it possible to compared
data obtained by different services.
The stimulus that is used varies in relation to size, luminance,
contrast, and reversal index. The responses to lower stimuli have
smaller amplitudes. Squares measuring 48´ (0.8º) are recommen-
ded for clinical use, but the results of studies on the ideal square
size are controversial and show that there is also a dependence on
the area of the board. The luminance should always be constant and
greater than 80 cd/m². The contrast between the black and white
reversals should be maximized (close to 100%) and should never
be less than 80%. The reversal index will determine the type of
PERG obtained(11).
To perform the examination, three electrodes are used. The
reference electrode should be fixed in the outer canthus the eye. The
capture electrode (active) should remain in contact with the lower
bulbar conjunctiva. At our service, we use a DTL (Dawson-Trick-
Litzkow) type apparatus, which should be tangential to the inferior
corneal limbus being studied. A third electrode is called the ground
electrode and is placed in the glabellar region. The patient should
remain seated comfortably with non-dilated pupils and use ade-
quate optical correction for the viewing distance. The registry can
be binocular or monocular.
In a recent study, Alves et al.(12) reported amplitude and implicit
time values of 30 normal individuals using transient PERG following
the standard ISCEV protocol. The authors, in this study, used stimuli
of three different sizes that included visual angles of 60, 15, and 7.5
minutes of arc. The reversal frequency of the pattern was 1.9 Hz and
the contrast was 100%. They obtained the following amplitude
values for N35-P50 and P50-N95, respectively: 1.7, 1.6, 0.9, and 3.8,
2.8, 1.5 μV.
PHYSIOLOGICAL ORIGIN OF PERG
The cell origin of PERG is still a matter of controversy. Hollander
et al.(13) reported the extinction of PERG in cats after section of the
optic nerve. The authors observed a progressive decrease in the
amplitude of PERG response first at low spatial frequencies and
later at high frequencies, up until complete response elimination
four months later, yet the response to the electroretinogram (ERG)
by flash remained. Concomitantly, retrograde degeneration of the
RGC was demonstrated histologically. Thus, the authors suggested
that the response origin evoked by the reversal pattern would be
confined to the RGC. In another study, Harrison et al.(14) demonstra-
ted an important reduction in the P50 amplitude, but without
extinction of the wave, in a patient without light perception 30
months after resection of the optic nerve due to a glioma. That
author then suggested that PERG could have an effect in the most
external layers of the retina and does not reflect only the response
in the RGC.
Berninger, Schuurmans(15) and Schuurmans, Berninger(16) studied
the outcomes in humans of variations in the parameters of pattern
stimulation in relation to temporal frequency, luminance, and contrast.
These authors proposed that the P50 component depended, in
part, on the luminance of the stimulus and would be generated by
the most external layers of the retina. On the other hand, the N95
component demonstrated a strong correlation with the spatial
frequency of the stimulus, may be related to variations in contrast,
and may be generated by the RGC.
The hypothesis regarding different PERG wave component
origins was subsequently corroborated by clinical observations ma-
de by Holder(17). In this study, the author observed that the P50 and
N95 components could be selectively altered in retinal diseases
and diseases of the optic nerve, respectively. In particular, the P50
component was shown to be altered in all patients with retinal and
macular diseases. On the other hand, the N95 component was
abnormal in 81% of patients with diseases of the optic nerve while
the P50 component remained normal.
In seven patients examined with dominant optic atrophy, a
condition characterized histopathologically by loss of RGC, Bernin-
ger et al. reported selective loss of the N95 amplitude and a
normal P50 component(18). Subsequently, Holder et al.(19), reported
a reduction of the N95 amplitude in 13 patients with such condi-
tion. Yet, in more advanced cases, there was also a reduction of P50
latency without an extinction of the component. This finding is in
agreement with those of Harrison et al.(14) who reported a reduc-
tion of the P50 amplitude in a patient with surgical resection of the
optic nerve.
Thus, PERG has proved to be important in the evaluation of
diseases of the anterior visual pathway, particularly those in which
there is a generalized loss of RNFL. Among these, glaucoma, com-
pressive diseases of the optic chiasm, and demyelinating diseases
stand out. Next, we will review the main studies that have used
PERG for evaluating disorders of the anterior visual pathway.
HEREDITARY OPTIC NEUROPATHIES
The hereditary diseases that most commonly cause primary
dysfunction of the RGC are: Leber’s hereditary optic neuropathyFigure 1. Representative example of a pattern electroretinogram response.
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(LHON) and dominant optic atrophy (DOA). LHON is a disease that
primarily affects men in the second and third decade of life, trans-
mitted through a maternally inherited mitochondrial DNA mu-
tation. This disease is characterized by subacute, painless, usually
severe and initially monocular loss of visual acuity (VA). In addition,
there is hyperemia of the optic disc with peripapillary telangiecta-
sias and a cecocentral defect of the visual field (VF). The other eye is
affected within weeks or months after the first eye(20). The main
characteristics of PERG in these patients is a marked acute reduc-
tion of the N95 component with preservation of the P50 compo-
nent as demonstrated by Holder(21). The preferential involvement
of the N95 component exhibits a strong correlation between this
wave with the loss of RGC with preservation of the P50 component,
which suggests a more external retinal origin and not only RGC
involvement.
DOA is an autosomal dominant hereditary disease caused by a
mutation in the OPA1 gene, located in the long arm of chromoso-
me 3. This disease is associated with progressive visual loss, optic
disc pallor, cecocentral VF defect and loss of color vision. Berninger
et al.(18) reported electrophysiological abnormalities in seven pa-
tients with DOA. Three were severely impaired and demonstrated
a reduction in the amplitude of the N95 component in addition to
a reduction of P50 latency and amplitude. Yet, Holder et al.(19) obser-
ved a preferential reduction of the N95 component during initial
phases of the disease and a reduction in the amplitude and latency
of P50 at more advanced phases.
DEMYELINATING INJURIES OF THE OPTIC NERVE
Involvement of the anterior optic nerve is an important mani-
festation of multiple sclerosis (MS). MS is clinically characterized by
episodes of focal involvement of the optic nerve, the brain paren-
chyma, and the spinal cord, with periods of exacerbation and re-
mission that are separated both in time and locations of the lesion.
MS preferentially affects female individuals at a ratio of nearly 2:1.
Initial symptoms generally occur between 30 and 50 years of age,
although children and elderly may also be affected.
Visual dysfunction occurs in 80% of patients with MS during the
course of the disease. Although it may affect any part of the visual
pathway, involvement predominantly occurs at the level of the optic
nerves. Visual loss may be acute, insidious or even be asymptomatic.
When acute, it manifests itself in the form of optic neuritis, charac-
terized by unilateral visual acuity (VA) loss that evolves over a period
of a few days, associated with periocular pain, decrease in color
vision, contrast sensitivity, a relative afferent pupillary defect, and
predominantly central VF defects. Fundus eye examination may be
normal when optic neuritis is retrobulbar or the disc margins may
be blurred in papillitis. VA loss ranges from subtle to absence of
light perception. There is a tendency toward improvement in the
VA and fields, while contrast sensitivity present a lesser tendency to
recover(22).
For the acute, insidious, and asymptomatic forms, the characte-
ristic pathological process in MS is inflammatory demyelination of
the axons, which leads to atrophy of the optic nerve. Axonal loss is
present particularly in chronic lesions and is responsible for the
persistence of neurological deficiencies and visual dysfunction. Its
assessment can be useful monitoring evolution of the disease.
Several authors have reported PERG abnormalities in patients
with demyelinating neuritis because the exam is capable of detec-
ting RGC dysfunction. Arden et al.(23) first reported a reduction in PERG
amplitude parameters among patients affected by optic neuritis,
suggesting retrograde axonal degeneration of RGC. The authors
found evidence that PERG was generated by layers that were closer
to the retina than those evaluated by multifocal electroretinogram.
Serra et al.(24), reported a reduction in the PERG amplitude among
patients affected by recurrent optic neuritis caused by MS. The
amplitude measured by these authors was from the peak of the
first positive wave, called a, to the trough of the second negative
wave, called b. Thus, these authors did not obtain evidence of
changes specific to each kind of wave, thereby not allowing charac-
terization of the most common type of alteration in these cases.
Similar results have been reported by other authors(25,26). On the
other hand, Kirkham, Coupland(27) did not find differences between
the PERG amplitudes in patients with MS related optic neuritis and
normal controls and concluded that PERG did not satisfactorily
reflect optic nerve dysfunction.
Holder(17), however, demonstrated specific abnormalities for
each PERG wave in patients with optic nerve diseases including optic
neuritis. He reported that 81% of patients with abnormal PERG
from optic nerve disorders presented reduction in the N95 ampli-
tude parameter while sparing the P50 component. In the same study,
all patients with retinal or macular dysfunction invariably demons-
trated P50 abnormalities. Thus, the author suggested that RGC loss
from optic nerve diseases resulted in specific alterations of the N95
component of PERG. In another study, Holder(28) found that among
optic neuritis patients with visual evoked potential abnormalities 40%
demonstrated PERG abnormalities, 85% of them with isolated N95
amplitude reduction.
Berninger, HeidereiderHi(29) described the PERG abnormalities
among 20 patients affected by acute optic neuritis after remission
of their disease. According to their report, there was a reduction in
P50 amplitude in all patients and a reduction in the N95 amplitude in
18 patients during an acute episode of optic neuritis. After remission,
there was recovery of the P50 component to normal levels, yet the
reduction in N95 persisted.
NONARTERITIC ANTERIOR ISCHEMIC OPTIC
NEUROPATHY (NAION)
Nonarteritic anterior ischemic optic neuropathy (NAION) is cau-
sed by a sudden and irreversible ischemic event that affects the
optic nerve. NAION affects elderly patients, usually older than 50
years of age, and causes sudden visual loss and altitudinal VF
defects. In addition to age, other risk factors associated with NAION
include diabetes mellitus, hypertension, tobacco use, and crowded
optic nerve.
There are few PERG studies in patients with NAION. Froehlich,
Kaufman(30) and Atilla et al.(31), reported a N95 amplitude reduction
and normal P50 amplitude and latency. Parisi et al.(32), described a
reduction in the amplitude of the P50-N95 component in a patient
with NAION and an increase in P50 latency. These authors sugges-
ted that the alterations may be the result of ischemic dysfunction
in the retina. Insufficiency of the blood supply would probably
also induce alterations in the layers anterior to the RGC, thereby
causing retinal dysfunction and abnormalities in the P50 compo-
nent of PERG.
COMPRESSIVE LESIONS OF THE ANTERIOR
VISUAL PATHWAY
Compressive lesions of the anterior visual pathway are those that
affect the optic nerve in its entirety and the optic chiasm. Compres-
sive intraorbital lesions cause chronic and unilateral loss of visual
acuity associated with edema of the ipsilateral optic nerve and
frequently cause proptosis as well. Among these lesions, the tumors
(gliomas and meningiomas of the optic nerve and orbital heman-
giomas) and inflammatory lesions (orbital pseudotumor and ophthal-
mopathy dysthyroid) stand out. Even though these injuries cause
compression of the optic nerve, the most common cause of visual
loss associated with compression of the anterior optic nerve are
chiasmal tumors, among which pituitary adenomas stand out. These
types of tumors commonly lead to visual dysfunction in both eyes.
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Among the visual functions impaired, the VF must be highlighted,
both in the diagnosis and monitoring of the disease. The characte-
ristic field defect with chiasmal disorders is bitemporal hemianop-
sia, which may be complete or incomplete. Despite being impor-
tant for the assessment of chiasmal disorders, examination of the
VF, by itself, does not permit, in a single examination, differentia-
tion between an active chiasmal lesion (a tumor still compressing
the optic chiasm) and a non-active lesion (which is a compression
lesion that has already been treated). Patients with a field defect
resulting from active compression of the optic pathway may de-
monstrate an improvement in visual dysfunction if they are proper-
ly treated. On the other hand, non-active defects do not improve
despite clinical treatment or surgery. Information in regards to the
reversibility or lack thereof of visual dysfunction is of fundamental
importance from a clinical point of view, as it is an important factor
when making a therapeutic decision. Thus, a structural evaluation of
the RNFL and RGC becomes relevant. In addition, in chiasmal com-
pressions, there is a predominant loss of nerve fibers originating in
the nasal retina of both eyes resulting in atrophy along a band of
the optic nerves, which is characteristic of this disease. This type of
neural loss serves as an interesting model for correlations between
structure and function.
Ruther et al.(33), evaluated 19 patients with previous active chias-
mal compression 5 to 10 days after surgical resection of a tumor
using steady-state and transitory PERG. For both techniques, there
was a positive correlation between the amplitude of PERG and the
visual results after surgery. The patients who demonstrated greater
amplitudes prior to the operation remained stable or improved
after the surgery leading the authors to suggest that PERG could
still be useful for predicting visual prognosis following surgery.
In another study, Parmar et al.(34), also studied PERG as an indicator
of visual prognosis during the preoperative evaluation of patients
with active chiasmal compression. They reported an improvement
in the VF in 65% of patients who demonstrated a normal N95/P50
index. Among patients who presented an abnormal N95/P50
index, only 27% had an improvement in their VF after decompres-
sion. The VF remained unaltered in 26% of the eyes with a normal
N95/P50 index compared to 67% of those with an abnormal index.
Thus, the authors suggest that PERG may be a valuable tool for
assessing the prognosis in these patients.
In a previous study we demonstrated that PERG was useful for
differentiatiating between patients with band atrophy of the optic
nerve from normal controls(35). Band atrophy patients demonstra-
ted P50 and N95 amplitudes that were significantly smaller than
that of controls when there was a full-field stimulus. There was no
significant difference for latency. In the same study, stimulation of
the nasal and temporal hemifields was also performed. In both cases,
there was a significant difference in the P50 and N95 amplitudes
between patients and controls. The decrease in PERG amplitude
that was obtained when the nasal sector of the retina was stimula-
ted probably reflected axonal damage of such fibers prior to the
surgical decompression.
We have also evaluated the relationship between OCT, PERG
and standard automated perimetry (SAP) in eyes with temporal
hemianopia from chiasmal compression(36). Forty-one eyes from 41
patients with permanent temporal VF defects from chiasmal com-
pression and 41 healthy subjects underwent transient full-field and
hemifield (temporal or nasal) stimulation PERG, SAP and time
domain-OCT macular and RNFL thickness measurements. Deviation
from normal VF sensitivity for the central 18° of VF was expressed in
1/Lambert units. PERG and OCT measurements were significantly
lower in eyes with temporal hemianopia than in normal eyes. A
significant correlation was found between VF sensitivity loss and
full-field or nasal, but not temporal, hemifield PERG amplitude.
Likewise a significant correlation was found between VF sensitivity
loss and most OCT parameters. No significant correlation was obser-
ved between OCT and PERG parameters, except for nasal hemifield
amplitude. A significant correlation was observed between several
macular and RNFL thickness parameters. The study indicated that
in patients with chiasmal compression, PERG amplitude and OCT
thickness measurements were significant related to VF loss, but not
to each other. The conclusion was that OCT and PERG quantify
neuronal loss differently, but both technologies are useful in un-
derstanding structure-function relationship in patients with chias-
mal compression.
PERSPECTIVES
PERG has proven to be of important value for the evaluation of
diseases that affect the anterior visual pathway. Abnormalities in
the amplitude of the N95 component is strongly correlated with
RGC dysfunction. On the other hand, the P50 component appears to
reflect dysfunctions in the layers anterior to the RGC and are
altered in macular and retinal diseases. N95 wave can therefore be
useful for documenting and monitoring RGC abnormalities.
An important limitation of PERG in the study of visual pathway
disorders, however, is the fact that normal responses can be obtai-
ned when small lesions focally affect the RGC and the RNFL. In these
cases, full-field PERG may not show the exact location of retinal
damage. A very important perspective was introduced recently
after the incorporation of the multifocal analysis technique develo-
ped by Sutter and Tran(37). In their technique, multiple stimuli are
presented simultaneously, thereby generating multiple responses
in small areas of the central retina. The variation in luminance is
independent for each area tested and the presentation of stimuli is
modulated in a pseudo-random manner. Thus, it is possible to
obtain a multifocal electroretinogram and, more recently, a multi-
focal PERG (mfPERG). The mfPERG combines a standard stimulus
with constant luminance and a multifocal technique with the goal
of identifying focal damage to the RGC.
Few studies have evaluated mfPERG for macular or optic nerve
diseases. Two previous studies have shown that mfPERG is capable
of identifying patients with RGC loss from glaucoma and can diffe-
rentiate them from normal controls(38,39). Yet, in these studies, the
authors did not find correlation between VF defects and PERG am-
plitude reduction. Klistoner et al.(38), evaluated the response of 15
patients with well defined glaucomatous and scotoma damage of
the VF using mfPERG stimulation. There was a statistically signifi-
cant reduction in the average amplitude for patients in relation to
controls, but no differences in latencies were found. However, the
reduction in the amplitudes did not correspond topographically
to the location of the scotoma in patients with glaucoma. Stielfel-
meyer et al.(39), studied 23 patients with glaucoma in different stages
of the disease. The authors reported reduced amplitudes using
mfPERG in relation to normal controls, mainly in the central area.
There was a correlation between the severity of the disease and
amplitude reduction in the central area, yet there was no correla-
tion with VF defects. It seems therefore that various factors can
influence the correlation between reduced amplitudes measured
by mfPERG and VF defects.
We recently studied a group of patients with band atrophy of
the optic nerve and permanent temporal field loss due to prior
compression of the chiasm due to pituitary adenomas(40). Twenty-
three eyes of patients with band atrophy and 21 control eyes were
studied in order to evaluate the ability of mfPERG to detect neural
loss and assess the relationship between mfPERG and VF loss in eyes
with chiasmal compression. Mean values of mfPERG amplitudes
from the temporal hemifield and temporal quadrants were signifi-
cantly lower in eyes with band atrophy than in controls. No signifi-
cant difference was observed in nasal hemifield measurements.
Significant correlations were found between VF relative sensitivity
and mfPERG amplitude in different VF sectors. We concluded that
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mfPERG amplitude measurements clearly differentiate eyes with
temporal VF defect from controls. The good correlation between
mfPERG amplitudes and the severity of VF defect suggests mfPERG
may be used as an indicator of ganglion cell dysfunction and opens
the perspective of use of such technology for quantification of
localized neural loss in lesions of the anterior visual pathways. Howe-
ver, although promissing for the future, mfPERG still needs more
studies to evaluate its potential role in demonstrating dysfunctions
located at the retinal ganglion cell layer and its correlation with
visual field defect.
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